TransMedics Group (NASDAQ: TMDX) has announced that it will be unveiling its third quarter financial results on Monday 28th October 2024. This eagerly anticipated announcement is scheduled to occur after market close, ensuring that investors and analysts have the opportunity to gain valuable insights into the company's performance during the quarter.
Wall Street financial analysts are foreseeing that the organization is likely to announce an estimated per share $0.29 profit for the quarter. Furthermore, it is anticipated that the company will disclose a total revenue of $115 million during the quarter.
The earnings report for the corresponding quarter of the prior year unveiled a per-share income of $0.12. This was a direct result of the company's total revenue, which amounted to an impressive $66.43 million during that specific period.
The experts on Wall Street have shared their predictions for how well the company will do this year. They think the total revenue will be around $444.36 million. They also believe the company will reach about profit of $1.26 per share for the fiscal year.
TransMedics Group (TMDX) closed Thursday's regular trading session at $122.00, demonstrating a 2.81 percent advance. The stock fluctuated between $119.07 and $123.94 during the day, with a volume of 1.30 million shares.
